MedPath
NMPA Approval

Risperidone Oral Solution

国药准字H20233562

May 19, 2023

Drug Information

利培酮口服液

口服溶液剂

0.1%(30ml:30mg)

化学药品

May 19, 2023

Company Information

Applicant Company

浙江省兰溪市康恩贝大道1号

Manufacturing Company

浙江省兰溪市康恩贝大道1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利培酮口服液 - NMPA 批准文号 | MedPath